Research advances in molecular genetics of epilepsies;Postepy w badaniach nad genetyka molekularna padaczek

Neurologia i Neurochirurgia Polska

Volumn 39, Issue 6, 2005, Pages 497-508

  Jóźwiak, Sergiusz ^a   Lasoń, Władysław ^b   Bijak, Maria ^b   Kotulska, Katarzyna ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Epilepsy; Epilepsy syndrome; Genetics; Ion channels; Receptors

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ION CHANNEL; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

BIOCHEMISTRY; DATA BASE; DISEASE CLASSIFICATION; EPILEPSY; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; MOLECULAR GENETICS; PATHOGENESIS; PHENOTYPE; PROTEIN FUNCTION; REVIEW; SEIZURE;

CALCIUM CHANNELS; CHLORIDE CHANNELS; EPILEPSY; HUMANS; ION CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; RECEPTORS, GABA; RECEPTORS, NICOTINIC; SODIUM CHANNELS;

EID: 30344481673     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Connor M., Ferguson-Smith M. Essential medical genetics. Blackwell Science Ltd., Oxford, UK 2000.
2. Hirose S., Mitsudome A., Okada M. i wsp. Genetics of idiopathic epilepsies. Epilepsia 2005; 46 (Suppl. 1): 38-43.
3. Baulac S., Huberfeld G., Gourfinkel-An I. i wsp. First genetic evidence of GABA (A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet 2001; 28: 46-48.
4. Ramakrishna L., Hess G.P. On the mechanism of a mutated and abnormally functioning gamma-aminobutyric acid (A) receptor linked to epilepsy. Biochemistry 2004; 43: 7534-7540.
5. Kullmann D.M., Hanna M.G. Choroby neurologiczne spowodowane dziedzicznymi mutacjami kanałów jonowych. The Lancet Neurology PL 2003; 1: 29-40.
6. Fisher J.L. A mutation in the GABAA receptor alpha1 subunit linked to human epilepsy affects channel gating properties. Neuropharmacology 2004; 46: 629-637.
7. Niemeyer M.J., Yusef Y.R., Cornejo I. i wsp. Functional evaluation of human ClC-2 chloride channel mutations associated with idiopathic generalized epilepsies. Physiol Genomics 2004; 19: 74-83.
8. Haug K., Warnstedt M., Alekov A.K. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat Genet 2003; 33: 527-532.
9. Goldin A.L. Mechanisms of sodium channel inactivation. Curr Opin Neurobiol 2003; 3: 284-290.
10. Rhodes T.H., Lossin C., Vanoye C.G. i wsp. Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy. Proc Natl Acad Sci USA 2004; 101: 11147-11152.
11. Yamakawa K. Epilepsy and sodium channel gene mutations: gain or loss of function? Neuroreport 2005; 16: 1-3.
12. Pineda-Trujillo N., Carrizosa J., Cornejo W. i wsp. A novel SCN1A mutation associated with severe GEFS+ in a large South American pedigree. Seizure 2005; 14: 123-128.
13. Steinlein O.K. Channelopathies can cause epilepsy in man. Eur J Pain 2002; 6 (Suppl. A): 27-34.
14. Nahm S.S., Jung K.Y., Enger M.K. i wsp. Differential expression of T-type calcium channels in P/Q-type calcium channel mutant mice with ataxia and absence epilepsy. J Neurobiol 2005; 15: 352-360.
15. Imbrici P., Jaffe S.L., Eunson L.H. Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain 2004; 127: 2682-2692.
16. Coppola G., Castaldo P., Miraglia del Giudice E. A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes. Neurology 2003; 61: 131-134.
17. Borgatti R., Zucca C., Cavallini A. i wsp. A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation. Neurology 2004; 63: 57-65.
18. Holter J., Carter D., Leresche N. i wsp. A TASK3 Channel (KCNK9) Mutation in a genetic model of absence epilepsy. J Mol Neurosci 2005; 25: 37-52.
19. Hirose S., Okada M., Kaneko S. i wsp. Molecular genetics of human familial epilepsy syndromes. Epilepsia 2002; 43 (Suppl. 9): 21-25.
20. Phillips H., Favre I., Kirkpatrick M. i wsp. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet 2001; 68: 2325-2331.
21. Brodbeck J., Davies A., Courtney J.M. i wsp. The ducky mutation in Cacna2d2 results in altered Purkinje cell morphology and is associated with the expression of a truncated alpha 2 delta-2 protein with abnormal function. J Biol Chem 2002; 277: 7684-7693.
22. Camfield P., Camfield C. Epileptic syndromes in childhood: clinical features, outcomes, and treatment. Epilepsia 2002; 43 (Suppl. 3): 27-32.
23. Tharp B.R., Neonatal seizures and syndromes. Epilepsia 2002; 43 (Suppl. 3): 2-10.
24. Kullmann D. M. Genetics of epilepsy. J Neurol Neurosurg Psychiatry 2002; 73 (suppl. 2): 32-35.
25. George A.L. Molecular basis of inherited epilepsy. Arch Neurol 2004; 61: 473-478.
26. Steinlein, O., Anokhin, A., Yping, M. i wsp. Localization of a gene for the human low-voltage EEG on 20q and genetic heterogeneity. Genomics 1992; 12: 69-73.
27. Vogel, F., Fujiya Y. The incidence of some inherited EEG variants in normal Japanese and German males. Humangenetik 1969; 7: 38-42.
28. Watanabe K., Yamoto N., Negoro T. i wsp. Benign complex partial epilepsy in infancy. Pediatr Neurol 1987; 3: 208-211.
29. Guipponi M., Rivier F., Vigevano F. i wsp. Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q. Hum Mol Genet 1997; 6: 473-477.
30. Picard F., Bertrand S., Steinlei O.K. i wsp. Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine. Epilepsia 1999; 40: 1198-1209.
31. Robinson R., Gardiner M. Genetics of childhood epilepsy. Arch Dis Childhood 2000; 82: 121-125.
32. Dravet C., Bureau M., Oguni H. i wsp. Severe myoclonic epilepsy in infancy: Dravet syndrome. Adv Neurol 2005; 95: 71-102.
33. Oguni H., Hayashi K., Osawa M. i wsp. Severe myoclonic epilepsy in infancy: clinical analysis and relation to SCN1A mutations in a Japanese cohort. Adv Neurol 2005; 95: 103-107.
34. Claes L., Del-Favero J., Ceulemans B. i wsp. De novo mutations in the sodium channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001; 68: 1327-1332.
35. Wheless J.W., Kim H.L. Adolescent seizures and epilepsy syndromes. Epilepsia 2002; 43 (suppl. 3): 33-52.
36. Cossette P., Lortie A., Vanasse M. i wsp. Autosomal dominant juvenile myoclonic epilepsy and GABRA1. Adv Neurol 2005; 95: 255-263.
37. Durner M., Pal D., Greenberg D. Genetics of juvenile myoclonic epilepsy: faulty components and faulty wiring? Adv Neurol 2005; 95: 245-254.
38. Scheffer I.E., Berkovic S.F. Generalized epilepsy with febrile seizures plus: a genetic disorder with heterogeneous clinical phenotypes. Brain 1997; 120: 479-490.
39. Hirose S., Mohney R.P., Okada M. i wsp. The genetics of febrile seizures and related epilepsy syndrome. Brain Dev 2003; 25: 304-312.